CPAP machines for sleep apnea treatment have become increasingly connected over the past decade. Most modern devices include cellular or wifi connectivity that automatically transmits usage data to manufacturers and healthcare providers. This remote monitoring capability offers real benefits, but it’s also raising privacy concerns that the industry hasn’t adequately addressed.

The data collected is remarkably detailed. Not just whether you used the machine last night, but for how many hours, what pressures were delivered, how many apnea events occurred, whether you had mask leaks, your breathing patterns throughout the night, and in some cases, estimates of sleep quality and position changes.

For clinical purposes, this data is useful. Sleep physicians can monitor whether therapy is effective without waiting for patients to come in for follow-up appointments. They can identify problems like persistent mask leaks or inadequate pressure settings and make adjustments remotely. Patients who struggle with compliance can receive timely interventions.

Insurance companies love this data because it allows them to verify that patients are actually using their CPAP machines. Many insurance policies require proof of usage—typically at least four hours per night for 70% of nights—to continue covering equipment and supplies. Connected CPAP machines provide that proof automatically.

But this is where things get uncomfortable. The data is being used not just to optimize treatment, but to make coverage decisions that can affect patients’ access to therapy. If you’re not meeting the arbitrary compliance thresholds, your insurance might stop paying for replacement supplies or equipment.

The thresholds themselves are somewhat questionable. The four-hour minimum came from early CPAP studies and stuck around, but it’s not necessarily optimal for everyone. Some patients get meaningful benefit from less usage. Others need more than four hours to feel rested. The one-size-fits-all compliance metric ignores individual variation.

Data ownership is murky. Who owns the detailed sleep data your CPAP machine generates? You, as the patient whose body generated that data? The equipment manufacturer who built the device that collected it? The sleep clinic that prescribed the device? Your insurance company who’s paying for it?

The answer varies depending on jurisdiction and specific agreements, but patients generally have less control than you might expect. Many manufacturers’ privacy policies reserve broad rights to use aggregated or de-identified data for research and product development.

There’s value in that research. Analyzing patterns across thousands of users can identify design improvements or discover insights about sleep apnea treatment. But it’s happening largely without explicit patient consent or awareness. The privacy policies exist, but they’re dense legal documents that few patients read or understand.

Third-party data sharing is another concern. Some CPAP manufacturers share data with partners for research or commercial purposes. The partnerships are disclosed in privacy policies, but not prominently. Patients who assume their sleep data is confidential between them and their doctor might be surprised to learn how widely it’s actually being shared.

Data security is critical when dealing with health information, and connected medical devices have had security vulnerabilities. CPAP machines aren’t high-value targets for hackers compared to systems with financial data, but they’re medical devices transmitting personal health information, which should be protected.

Some manufacturers have had security issues. Unencrypted data transmission, weak authentication, or vulnerabilities in companion apps have been identified and patched. But the cat-and-mouse game of security vulnerabilities is ongoing, and medical device manufacturers don’t always have the security expertise of technology companies.

Patient autonomy is getting squeezed between medical benefit and administrative convenience. Remote monitoring genuinely helps some patients achieve better outcomes. But mandatory connectivity that feeds into compliance-based insurance decisions starts feeling coercive.

What if you want CPAP therapy but don’t want your nightly usage data transmitted to multiple organizations? In practice, your options are limited. Most newer machines have connectivity built in and activated by default. Opting out might be possible technically, but it could affect your ability to get insurance coverage or participate in remote care programs.

Some patients have figured out workarounds—disabling wifi, blocking cellular signals, or using older non-connected machines. But this shouldn’t be necessary. Patients should be able to consent meaningfully to data collection and choose whether to participate without sacrificing access to effective treatment.

The medical device industry argues that connectivity improves outcomes and reduces healthcare costs through better compliance and earlier problem detection. There’s truth to that. But it’s also true that connectivity serves the economic interests of manufacturers, providers, and insurers in ways that don’t always align with patient interests.

Regulatory oversight is playing catch-up. Medical device regulations focus primarily on safety and efficacy, not privacy and data governance. Privacy laws like GDPR in Europe and various state laws in the US apply, but medical device data often falls into gaps between different regulatory frameworks.

Patients need clearer information about what data is collected, who receives it, how it’s used, and what choices they have. The current approach—burying this information in terms of service and privacy policies—fails basic standards for informed consent.

Transparency from manufacturers would help. If companies clearly explained their data practices, allowed patients to opt in or out of specific uses, and minimized collection to what’s clinically necessary, many concerns would be addressed.

Insurance requirements based on compliance data need rethinking too. Using CPAP data to identify patients who need additional support makes sense. Using it punitively to deny coverage for patients who struggle with therapy is counterproductive and ethically questionable.

Some healthcare systems are exploring different models. Providing the compliance data to patients and their doctors but not automatically sharing it with insurers. Using data for care management but not for coverage decisions. These approaches preserve the clinical benefits while reducing the coercive aspects.

Alternative compliance verification methods exist. Patients could manually track usage. Doctors could assess compliance based on clinical symptoms and patient reports rather than automated data. These approaches worked before connected CPAP machines existed, and they still work now.

The technology isn’t inherently problematic. Remote monitoring can genuinely improve care when implemented thoughtfully with proper consent and safeguards. The problem is how it’s currently being deployed—often with minimal patient choice and inadequate privacy protection.

The sleep medicine community needs to engage with these concerns more seriously. Dismissing patient privacy worries as obstacles to beneficial technology misses the point. Patients can and should be able to benefit from connected health devices without surrendering control over their personal health data.

There’s a path forward that respects both clinical utility and patient autonomy. Clearly disclosed data collection. Meaningful consent processes. Patient control over who receives their data and for what purposes. Limiting insurance use of compliance data to supportive rather than punitive applications.

Until we get there, the current system will continue creating tension between the medical value of CPAP therapy and patients’ reasonable expectations of privacy and autonomy. That’s a tension the field should work to resolve rather than ignore.